The decision follows positive recommendation from the Institut national d’excellence en santé et services sociaux (INESSS) recognising the urgency and […]
Proposed acquisition builds on existing agreement with CellforCure for contract manufacturing of Novartis leading CAR-T cell therapy Kymriah® (tisagenlecleucel) and […]